Home › Atherosclerosis › Minnesota
Atherosclerosis clinical trials in Minnesota
6 studies for Atherosclerosis are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- University of Minnesota, Minneapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07448038Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- Minneapolis Heart Institute Foundation, Minneapolis
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DCR Edina, Minneapolis
- Minneapolis VA Health Care System, Minneapolis
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Duluth
- Research Site, Minneapolis
- Research Site, Minneapolis
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
- Allina Health, Minneapolis
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06471036Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.